EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) — Biofacturing leader Zymergen today announced the company will be participating in the upcoming UBS Global Healthcare Virtual Conference.
Zymergen’s management is scheduled to present on Wednesday, May 26th at 3:00 p.m. Eastern Time/12:00 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.zymergen.com/.
About Zymergen
Zymergen is a biofacturing company using biology to reimagine the world. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.
Investor Contact
Niraj Javeri
investors@zymergen.com
Media Contact
Mike Dulin
mdulin@zymergen.com
502-777-2029
KARACHI, Pakistan, Dec. 22, 2025 /PRNewswire/ -- MindHYVE.ai, Inc., and Khoja (Pirhai) Shia Isna Asheri Jamaat…
Board-certified plastic surgeon and surgeon-scientist honored for clinical excellence, leadership, and commitment to patient education. …
New "Recovery Logistics" checklist helps patients coordinate work, childcare, travel, and follow-up support-before they choose…
Board-certified plastic surgeon shares a practical, question-based guide to help patients verify credentials, facility standards,…
ASPS trend reporting highlights facelift combined with eyelid surgery as a leading 2025 combination; national…
SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI)…